Wells Fargo & Company Ani Pharmaceuticals Inc Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 10,169 shares of ANIP stock, worth $597,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,169

Previous 7,493 35.71%

Holding current value

$597,225

Previous $447,000 25.73%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$53.35 - $61.74 $142,764 - $165,216	2,676 Added 35.71%	10,169 $562,000
Q3 2024 Nov 13, 2024	SELL	$54.33 - $65.72 $245,028 - $296,397	-4,510 Reduced 37.57%	7,493 $447,000
Q2 2024 Aug 13, 2024	BUY	$58.53 - $68.82 $398,179 - $468,182	6,803 Added 130.83%	12,003 $764,000
Q1 2024 May 10, 2024	BUY	$54.2 - $69.69 $30,568 - $39,305	564 Added 12.17%	5,200 $359,000
Q4 2023 Feb 09, 2024	BUY	$48.72 - $65.43 $45,017 - $60,457	924 Added 24.89%	4,636 $255,000
Q3 2023 Nov 13, 2023	SELL	$50.28 - $64.61 $151,091 - $194,153	-3,005 Reduced 44.74%	3,712 $215,000
Q2 2023 Aug 15, 2023	BUY	$37.29 - $53.83 $115,002 - $166,011	3,084 Added 84.89%	6,717 $361,000
Q1 2023 May 12, 2023	BUY	$37.61 - $45.72 $102,035 - $124,038	2,713 Added 294.89%	3,633 $144,000
Q4 2022 Feb 13, 2023	SELL	$31.9 - $41.95 $12,122 - $15,941	-380 Reduced 29.23%	920 $37,000
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $38,182 - $48,652	-1,280 Reduced 49.61%	1,300 $41,000
Q2 2022 Aug 12, 2022	SELL	$23.09 - $33.46 $131,497 - $190,554	-5,695 Reduced 68.82%	2,580 $76,000
Q1 2022 May 16, 2022	SELL	$26.91 - $47.15 $306,585 - $537,179	-11,393 Reduced 57.93%	8,275 $233,000
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $74,644 - $128,708	2,264 Added 13.01%	19,668 $907,000
Q3 2021 Nov 15, 2021	SELL	$26.48 - $35.99 $102,345 - $139,101	-3,865 Reduced 18.17%	17,404 $571,000
Q2 2021 Aug 16, 2021	SELL	$31.86 - $38.6 $162,231 - $196,551	-5,092 Reduced 19.32%	21,269 $745,000
Q1 2021 May 13, 2021	SELL	$28.4 - $36.14 $264,205 - $336,210	-9,303 Reduced 26.09%	26,361 $952,000
Q4 2020 Feb 09, 2021	SELL	$23.69 - $31.47 $375,154 - $498,358	-15,836 Reduced 30.75%	35,664 $1.04 Million
Q3 2020 Nov 05, 2020	SELL	$26.38 - $33.1 $49,779 - $62,459	-1,887 Reduced 3.53%	51,500 $1.45 Million
Q2 2020 Aug 13, 2020	BUY	$29.93 - $50.1 $533,232 - $892,581	17,816 Added 50.09%	53,387 $1.73 Million
Q1 2020 May 14, 2020	BUY	$30.35 - $67.14 $1.08 Million - $2.39 Million	35,571 New	35,571 $1.45 Million

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

19.2M

Call Options Held

3.4K

Put Options Held

10.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ani Pharmaceuticals Inc Transaction History